High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy

被引:24
作者
Kanengisser-Pines, Bibi [1 ,2 ]
Hazan, Yenon [1 ,2 ]
Pines, Guy [2 ,3 ]
Appelman, Zvi [2 ,4 ]
机构
[1] Kapiolani Med Ctr, Dept Obstet & Gynecol, IL-76100 Rehovot, Israel
[2] Hadassah Hebrew Univ, Sch Med, Jerusalem, Israel
[3] Kapiolani Med Ctr, Dept Surg B, IL-76100 Rehovot, Israel
[4] Kapiolani Med Ctr, Clin Genet Ctr, IL-76100 Rehovot, Israel
关键词
Amniotic fluid; avidity; cytomegalovirus; infection; pregnancy; REAL-TIME PCR; CMV INFECTION; DIAGNOSIS; WOMEN; RISK; ANTIBODIES; ASSAYS;
D O I
10.1515/JPM.2009.012
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the accuracy of high cytomegalovirus (CMV) specific IgG avidity in excluding recent infection in patients with anti-CMV IgM antibodies detected during the first trimester, using amniotic fluid obtained by standard amniocentesis. Methods: Records of all patients with a positive anti-CMV IgM with IgG avidity) 65% detected during pregnancy were reviewed. Amniocentesis for CMV assessment was offered to all patients. The presence of the virus in amniotic fluid was determined by polymerase chain reaction (PCR) and shell vial testing. Results: Seventy-nine patients with a positive CMV IgM-high IgG avidity combination were identified. The serological tests were performed during the first trimester in 65 (82.3%) patients, of which 28 consented and underwent amniocentesis. All amniotic fluid samples were negative for CMV-PCR and CMV shell vial testing. Conclusions: IgG avidity above 65% is a good indicator of past infection, and thus excludes CMV in the amniotic fluid. In such circumstances, invasive prenatal diagnosis may eventually not be required. This optimistic conclusion, however, needs to be confirmed by large scale studies.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 22 条
[1]  
ALFORD CA, 1990, REV INFECT DIS, V12, pS743
[2]   Anticytomegalovirus IgG avidity in pregnancy:: A 2-year prospective study [J].
Bodéus, M ;
Van Ranst, M ;
Bernard, P ;
Hubinont, C ;
Goubau, P .
FETAL DIAGNOSIS AND THERAPY, 2002, 17 (06) :362-366
[3]   Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection [J].
Bodéus, M ;
Goubau, P .
JOURNAL OF CLINICAL VIROLOGY, 1999, 12 (01) :3-8
[4]   Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection [J].
Bodéus, M ;
Beulné, D ;
Goubau, P .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (04) :248-252
[5]   Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women [J].
Bodeus, M ;
Feyder, S ;
Goubau, P .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1998, 9 (01) :9-16
[6]   Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR [J].
Boeckh, M ;
Huang, M ;
Ferrenberg, J ;
Stevens-Ayers, T ;
Stensland, L ;
Nichols, WG ;
Corey, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) :1142-1148
[7]  
BRITT WJ, 1996, FIELDS VIROLOGYT
[8]  
Eggers M, 2000, J MED VIROL, V60, P324, DOI 10.1002/(SICI)1096-9071(200003)60:3<324::AID-JMV11>3.0.CO
[9]  
2-D
[10]  
GENEVIEVE RE, 1996, J MED VIROL, V50, P9